Noncoding RNAs in age-related cardiovascular diseases

Ageing Res Rev. 2022 May:77:101610. doi: 10.1016/j.arr.2022.101610. Epub 2022 Mar 23.

Abstract

Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality in the adult population worldwide and represent a severe economic burden and public health concern. The majority of human genes do not code for proteins. However, noncoding transcripts play important roles in ageing that significantly increases the risk for CVDs. Noncoding RNAs (ncRNAs) are critical regulators of multiple biological processes related to ageing such as oxidative stress, mitochondrial dysfunction and chronic inflammation. NcRNAs are also involved in pathophysiological developments within the cardiovascular system including arrhythmias, cardiac hypertrophy, fibrosis, myocardial infarction and heart failure. In this review article, we cover the roles of ncRNAs in cardiovascular ageing and disease as well as their potential therapeutic applications in CVDs.

Keywords: Ageing; Cardiovascular disease; Inflammageing; Noncoding RNAs.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / genetics
  • Cardiovascular Diseases* / genetics
  • Cardiovascular System* / metabolism
  • Heart
  • Humans
  • MicroRNAs* / genetics
  • RNA, Long Noncoding* / genetics
  • RNA, Untranslated / genetics

Substances

  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Untranslated